文献速递药物不良反应与药物警戒特殊人群用药

医院至社区过渡期用药错误与药物相关伤害的系统综述

Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review.
PubMed 文献 · Drug Saf · 2020-01-01

该系统综述检索1990年1月至2019年3月十个数据库及灰色文献,纳入54项研究,评估出院后用药错误、无意用药差异及药物不良事件的患病率与性质。成人患者用药错误中位率53%、无意用药差异中位率50%、药物不良反应中位率27%、药物不良事件中位率19%;儿科用药错误率66.3%、药物不良事件率9%。涉及药物以抗菌药、降糖药、镇痛药和心血管药最常见。

要点

  • 成人出院后用药错误中位率53%,无意用药差异中位率50%。
  • 成人出院后药物不良反应中位率27%,药物不良事件中位率19%。
  • 抗菌药、降糖药、镇痛药和心血管药是最常涉及的药物类别。

核心结论

  • 这是首个探讨出院后用药错误与药物不良事件患病率及性质的系统综述。
  • 出院后用药错误和无意用药差异在成人中常见,中位率分别为53%和50%。
  • 药物不良反应和药物不良事件在成人出院后也较常见,中位率分别为27%和19%。

研究设计与样本

  • 系统综述检索1990年1月至2019年3月十个电子数据库及灰色文献,无语言或患者人群限制。
  • 纳入包含用药错误率、无意用药差异或药物不良事件数据的研究,共54项。
  • 多数研究质量评为中等(39/54)或高(7/54)。

主要发现

  • 成人出院后用药错误中位率53%(四分位距33-60.5,n=5项研究)。
  • 成人出院后无意用药差异中位率50%(四分位距39-76,n=11项研究)。
  • 五项研究报告药物不良反应率中位27%(四分位距18-40.5),七项研究报告药物不良事件率中位19%(四分位距16-24)。
  • 儿科一项研究报告用药错误率66.3%,另一项报告药物不良事件率9%。
  • 与药物不良事件最常相关的药物类别为抗菌药、降糖药、镇痛药和心血管药。

临床怎么用

  • 出院过渡期应重点关注抗菌药、降糖药、镇痛药和心血管药的用药核对与患者教育。
  • 对出院患者可系统筛查用药错误和无意用药差异,以减少药物相关伤害。

局限性

  • 近四分之一研究(13/54,24%)的出院后随访期为1个月(范围2-180天),随访时长差异较大。
  • 多数研究质量评为中等(39/54),高仅7/54,证据质量参差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the epidemiology of medication errors and medication-related harm following transition from secondary to primary care. This systematic review aims to identify and critically evaluate the available evidence on the prevalence and nature of medication errors and medication-related harm following hospital discharge. METHODS: Studies published between January 1990 and March 2019 were searched across ten electronic databases and the grey literature. No restrictions were applied with publication language or patient population studied. Studies were included if they contained data concerning the rate of medication errors, unintentional medication discrepancies, or adverse drug events. Two authors independently extracted study data. RESULTS: Fifty-four studies were included, most of which were rated as moderate (39/54) or high (7/54) quality. For adult patients, the median rate of medication errors and unintentional medication discrepancies following discharge was 53% [interquartile range 33-60.5] (n = 5 studies) and 50% [interquartile range 39-76] (n = 11), respectively. Five studies reported adverse drug reaction rates with a median of 27% [interquartile range 18-40.5] and seven studies reported adverse drug event rates with a median of 19% [interquartile range 16-24]. For paediatric patients, one study reported a medication error rate of 66.3% and another an adverse drug event rate of 9%. Almost a quarter of studies (13/54, 24%) utilised a follow-up period post-discharge of 1 month (range 2-180 days). Drug classes most commonly implicated with adverse drug events were antibiotics, antidiabetics, analgesics and cardiovascular drugs. CONCLUSIONS: This is the first systematic review to explore the prevalence and nature of medication errors and adverse drug events following hospital discharge. Targets for future work have been identified.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Alqenae FA, Steinke D, Keers RN, et al. Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. Drug Saf. 2020. PMID: 32125666. doi:10.1007/s40264-020-00918-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。